BRAF and neoplasm: The prevalence and type of BRAF exon 15 mutations in our PTCs are compatible with those reported in the literature; BRAF p.V600E was identified in 62.5% of classic PTC, in all tall cell PTC variants, and in the only infiltrative follicular variant PTC, all tumor types associated with a BRAF p.V600E-like mutational profile [2].